Search Results - "Granström, Ola"
-
1
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
Published in Therapeutic advances in psychopharmacology (01-08-2013)“…Background: Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment. Methods: We performed a systematic review…”
Get full text
Journal Article -
2
The societal cost of bipolar disorder in Sweden
Published in Social Psychiatry and Psychiatric Epidemiology (01-10-2013)“…Purpose There is a lack of comprehensive cost-of-illness studies in bipolar disorder, in particular studies based on patient-level data. The purpose of this…”
Get full text
Journal Article -
3
Cost-effectiveness of dapagliflozin (Forxiga® ) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries
Published in Primary care diabetes (01-02-2015)“…Highlights • Dapagliflozin – a sodium-glucose co-transporter 2 inhibitor working independently of insulin. • Long term diabetes-related complications are…”
Get full text
Journal Article -
4
Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis
Published in Neuropsychiatric disease and treatment (01-01-2013)“…The purpose of this study was to investigate the impact of dosing frequency on adherence in severe chronic psychiatric and neurological diseases. A systematic…”
Get full text
Journal Article -
5
Cost-effectiveness of saxagliptin (Onglyza® ) in type 2 diabetes in Sweden
Published in Primary care diabetes (01-07-2012)“…Abstract Aim The objective of this study was to investigate the cost-effectiveness of saxagliptin (Onglyza® ), a DPP-4 inhibitor, plus metformin compared with…”
Get full text
Journal Article -
6
The societal cost of schizophrenia in Sweden
Published in The journal of mental health policy and economics (01-03-2013)“…Schizophrenia is a disabling psychiatric disorder that has severe consequences for patients and their families. Moreover, the expensive treatment of…”
Get more information
Journal Article -
7
Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders
Published in BMJ open (01-01-2012)“…ObjectiveExtended release (XR) and immediate release (IR) quetiapine have differing dosing, titration and plasma concentration profiles. The authors assessed…”
Get full text
Journal Article -
8
Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension
Published in ClinicoEconomics and outcomes research (01-01-2012)“…Although angiotensin receptor blockers have different receptor binding properties, no comparative randomized studies with cardiovascular event endpoints have…”
Get full text
Journal Article -
9
Costs of bipolar disorder, depression, schizophrenia and anxiety. The right treatments can have significant positive socio-economic effects
Published in Läkartidningen (20-08-2014)Get more information
Journal Article